Management of Dentinal Hypersensitivity Using Two Dentifrice Technologies (NCT07511530) | Clinical Trial Compass
CompletedNot Applicable
Management of Dentinal Hypersensitivity Using Two Dentifrice Technologies
Jordan57 participantsStarted 2024-08-18
Plain-language summary
This study evaluates the effectiveness of Scigates foam mouth sanitizer 2 in 1 toothpaste and mouthwash in reducing tooth sensitivity and improving tooth whitening compared to Lacalut® White \& Repair toothpaste. Participants will be randomly assigned to either the Scigates group or the Lacalut control group and will use the assigned product three times daily for 8 weeks. Tooth sensitivity and dental staining will be assessed at multiple time points using standardized clinical scales. Safety will also be monitored throughout the study.
Who can participate
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Healthy male or female participants aged 18 to 65 years
* Individuals with mild to moderate tooth staining
* Individuals with self-reported tooth sensitivity to hot, cold, sweet, or acidic stimuli
* Ability and willingness to comply with all study procedures
* Provision of written informed consent
Exclusion Criteria:
* History of allergic reactions to any component of the study products
* Presence of clinically significant allergic disease
* Pregnant or lactating women
* Women of childbearing potential not using an acceptable method of contraception
* Individuals with severe tooth staining requiring professional treatment
* Individuals who have received recent treatment for tooth discoloration
* Individuals with severe periodontal disease requiring immediate intervention
* Individuals with significant dental conditions such as active caries, periodontal disease, or ongoing orthodontic treatment
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.